Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris

Next Previous
Trial Profile

LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary)
  • Indications Plaque psoriasis
  • Focus Registrational; Therapeutic Use
  • Acronyms PSO-FAST
  • Sponsors LEO Pharma

    • Most Recent Events

    • 12 Jul 2016 According to Leo Pharma media release, based on the results from PSO-FAST study and a phase II MUSE trial (Profile 217861), the company has launched Enstilar foam spray for psoriasis in the United Kingdom.
    • 26 Apr 2016 According to Leo Pharma media release, based on the results from this PSO-FAST study and other MUSE trial (see CTP 700217861), the company received marketing authorisation for Enstilar (calcipotriol/betamethasone dipropionate) for the topical treatment of plaque psoriasis in patients 18 years of age or older, in the United Kingdom.
    • 21 Mar 2016 Results published in a Leo Pharma media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top